Treating Heart Failure With Preserved Ejection Fraction

Abstract

Get full access to this article

View all access options for this article.

References

Athyros

Pagourelias

Gossios

Vasilikos

. Treating heart failure with preserved ejection fraction related to arterial stiffness. Can we kill two birds with one stone? Curr Vasc Pharmacol. 2013.

Cleland

JGF

Pellicori

. Defining diastolic heart failure and identifying effective therapies. JAMA. 2013;309(8):825–826.

Edelmann

Wachter

Schmidt

; Aldo-DHF Investigators. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA. 2013;309(8):781–791.

Wang

Dai

. Long-term clinical outcomes of statin use for chronic heart failure: a meta-analysis of 15 prospective studies [published online August 17, 2013]. Heart Lung Circ. 2013.

Athyros

Papageorgiou

Mercouris

. Treatment with atorvastatin to the National cholesterol educational program goal versus ‘usual’ care in secondary coronary heart disease prevention the GREek atorvastatin and coronary-heart-disease evaluation (GREACE) study. Curr Med Res Opin. 2002;18(4):220–228.

Khush

Waters

Bittner

. Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the treating to new targets (TNT) study. Circulation. 2007;115(5):576–583.

Jennifer E.

Waters

David D.

; TNT Investigators. Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the treating to new targets [TNT] study). Am J Cardiol. 2012;109(12):1761–1766.

Athyros

Karagiannis

Katsiki

Mikhailidis

. Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity. Am J Cardiol. 2012;110(5):763.

Athyros

Mikhailidis

Papageorgiou

. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. a subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol. 2004;57(7):728–734.

10.

Nikolic

Banach

Nikfar

; Lipid and Blood Pressure Meta-Analysis Collaboration Group. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? [published online August 28, 2013]. Int J Cardiol. 2013.